Page last updated: 2024-09-03

vadimezan and melphalan

vadimezan has been researched along with melphalan in 1 studies

Compound Research Comparison

Studies (vadimezan)	Trials (vadimezan)	Recent Studies (post-2010) (vadimezan)	Studies (melphalan)	Trials (melphalan)	Recent Studies (post-2010) (melphalan)
272	16	101	8,134	1,351	1,972

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Holford, NH; Pruijn, FB; van Daalen, M; Wilson, WR	1

Other Studies

1 other study(ies) available for vadimezan and melphalan

Article	Year
Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid. Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Cell Hypoxia; Drug Synergism; Female; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neovascularization, Pathologic; Xanthenes; Xanthones	1997

Article

Year

Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid.

Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:6

Topics: Animals; Antineoplastic Agents, Alkylating; Cell Hypoxia; Drug Synergism; Female; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neovascularization, Pathologic; Xanthenes; Xanthones

1997